Our vision

PB Immune Therapeutics, Inc

contributes to maintaining a healthy life for mankind through the regulation of immune function.

Company vision

The vision of PB Immune Therapeutics is to develop the "Immunomodulatory Therapeutics" capable of controlling immune function (activation, inhibition, and maintenance of homeostasis) and to establish a system that facilitates its safe and accurate clinical application.

Company value

  • Interest and Passion

    Interest and passion are
    the matrix of creative thinking
    and scientific approach.

  • Effort and Dedication

    From the principles of
    basic science, the development
    of therapeutic agents is
    possible only with diligent efforts
    and dedication without
    fear of failure.

  • Sincerity and Fidelity

    Only true research results
    obtained with sincerity
    lead to ultimate success.

  • Social service

    Social service that can return the
    benefits received from society to
    society is one of the important
    values that PB Immune
    Therapeutics Co., Ltd. pursues.

Company profile

  • Company name

    PB Immune Therapeutics Inc.

  • CEO

    Chung-Gyu Park

  • Establishment date

    2020.12.18.

  • Specialized Business Field

    Medical / Pharmaceutical R&D

  • Main Products

    Biologic medical product

  • Location

    71, Ihwajang-gil, Jongno-gu, Seoul, Republic of Korea

  • Number of Employees

    17 (as of 2023. 01.)

  • Website Address

    www.pbimmune.com

Company history

2022

  • 08.01

    Received the Korean New Drug R&D Project Grant for the treatment of Pemphigus Vulgaris from the Korean Drug Development Fund (KDDF)

  • 05.01

    Received the Start-up Leap-up Package Grant from Korea Institute of Startup & Entrepreneurship Development (KISED)

2021

  • 11.23

    Received the Korean New Drug R&D Project grant for the treatment of Multiple Sclerosis from the Korean Drug Development Fund (KDDF)

  • 11.03

    Venture company certification

  • 09.10

    Attracted Pre-A Series investment (Atinum)

  • 06.14

    Received an Initial Start-up Package Grant from Korea Institute of Startup & Entrepreneurship Development (KISED)

  • 05.20

    Establishment and accreditation of the company-affiliated Immune Regulation Research Center (IRRC)

  • 02.16

    Awarded in the ‘National Investor Contest’, a startup festival hosted by the Ministry of Science and Technology

  • 01.04

    Business registration

2020

  • 12.18

    Established a corporation (PB Immune Therapeutics)

  • 08.01

    Received a SNU Startup Project Grant (Task name: Lab-Specialized Startup Leading University)

Platform-to-Bedside,
Pathfinder of the Best therapeutics

피비이뮨테라퓨틱스

PB Immune Therapeutics contributes to the maintenance of human health through immunomodulatory therapeutics.

Collaborative researchers from all over the world

Global-scale collaborative research network